BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The American Association for Homeopathic Products - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://theaahp.org
X-WR-CALDESC:Events for The American Association for Homeopathic Products
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260610T120000
DTEND;TZID=America/New_York:20260610T133000
DTSTAMP:20260701T074007
CREATED:20260504T132359Z
LAST-MODIFIED:20260520T145023Z
UID:10000106-1781092800-1781098200@theaahp.org
SUMMARY:FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/fda-insights-on-gmp-violations-aahp-homeopathic-483-study-webinar/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://theaahp.org/wp-content/uploads/2022/05/AAHP-Logo-e1677699574756.png
ORGANIZER;CN="The American Association for Homeopathic Products":MAILTO:info@aahp.info
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260909T110000
DTEND;TZID=America/New_York:20260909T130000
DTSTAMP:20260701T074007
CREATED:20260615T125212Z
LAST-MODIFIED:20260615T125212Z
UID:10000107-1788951600-1788958800@theaahp.org
SUMMARY:AAHP 2026 Semi Annual Membership Meeting
DESCRIPTION:11:00 a.m. ET • 10:00 a.m. CT • 9:00 a.m. MT • 8:00 a.m. PT • 16.00 GMT • 17.00 CET \n\n	\n\n\n\n	\n		\n	\n\n\n	\n						\n		\n\n			\n	\n	\n		\n	Summary\nWhether your company is located in the U.S. or the E.U.\, you need to be aware of regulations on “the other” side of the ocean in today’s global market. This is especially true for homeopathic drugs\, the starting materials for many of which are available only from one continent or the other. \nHow do the regulations within the supplier’s country impact your ability to import those starting materials? What are the ramifications of the end marketer’s national requirements on the export of homeopathic starting materials? \nAttend this important and timely webinar to: \n\nReceive an overview of the regulatory frameworks for homeopathic drugs in the U.S. and E.U.;\nUnderstand the fundamental differences between the U.S. and E.U. regulatory requirements; and\nGain insights into what you need to know for importing and exporting homeopathic drugs between the U.S. and E.U.\n\nThis one-hour webinar will introduce your company to the myriad of aspects every company needs to consider in today’s international marketplace. Presented by two established experts in the field\, this webinar will provide companies with the framework to understand the differences and comparisons between the U.S. and E.U. regulatory requirements\, as well as the impact of “the other” on your company’s suppliers and markets. The webinar will also provide an awareness of the differences between the various national pharmacopeias and why an ignorance of “the other” can lead to your products being deemed as misbranded or adulterated. \n\n	\n\n\n	\n		\n	Presenters\nSteve Mann\, Director of External Global Regulatory Affairs & QPPV\, Nelsons\n\nSteve has worked with Nelsons for more than 15 years with 20 years experience in the field of global regulation for homoeopathic drugs\, cosmetics\, herbal and dietary supplements\, and medical devices. He has worked on and managed regulatory and compliance projects in North\, Central and South America\, Europe\, North and East Africa\, Asia\, and Australasia. \nSteve currently holds board positions with various industry trade bodies\, including the British Association of Homeopathic Manufacturers (BAHM)\, the European Coalition on Homeopathic and Anthroposophic Medicinal Products (ECHAMP)\, and the U.K. Health Food Manufacturers Association (HFMA). He is also a Member of the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) and sits on the Standards and Controls and Monograph Review Committees\, and the Council on Pharmacy. \nEric Foxman\, Consultant and Board Member\, HPCUS\nEric has a rich history of work in the homeopathic industry. He has been a member of the Homeopathic Pharmacopeia Convention of the United States since its founding in 1980 and is presently in his 12th year on the Board of Trustees. Eric serves as the Senior Scientist of the Convention and the Chair of the Council on Pharmacy. In these capacities\, Eric is very active in the on-going revision and updating of the contents of the HPUS. \nEric has been active a member or representative of the American Association of Homeopathic Pharmacists for over 38 years. He has presented numerous workshops on legal\, regulatory and technical aspects of the manufacturing and marketing of homeopathic drug products. He also presents updates to the HPUS through an annual webinar. Eric is a consultant to the homeopathic industry with a focus on helping companies achieve compliance with the myriad of regulatory requirements for companies’ high-quality\, well-formulated homeopathic drug products. \n\n	\n\n\n	\n		\n	Who Should Attend?\n\nAmerican companies purchasing homeopathic materials from Europe\nEuropean companies shipping homeopathic materials into the U.S.\nAmerican companies exporting or interested in exporting homeopathic products to Europe\nEuropean companies importing American homeopathic products\nCompliance managers\nPurchasing managers\nQuality managers\nThose responsible for import/export\n\n\n	\n\n\n	\n		\n	Cost\nNonmembers: $239\nAAHP Members: $149 (With $90 discount available from the AAHP office) \n  \n\n	\n\n\n	\n		\n	\n		Register Today!\n		\n	\n	\n		\n			\n							Click Here to Register
URL:https://theaahp.org/event/aahp-2026-semi-annual-membership-meeting/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://theaahp.org/wp-content/uploads/2022/05/AAHP-Logo-e1677699574756.png
ORGANIZER;CN="The American Association for Homeopathic Products":MAILTO:info@aahp.info
END:VEVENT
END:VCALENDAR